UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 425

Sortiert nach

Current issues in venous thromboembolism

Postgraduate medicine, 2021-08, Vol.133 (sup1), p.1-2

Cohen, David A

2021

Link zum Volltext

Verfügbarkeit prüfen

Thrombosis in multiple myeloma: mechanisms, risk assessment and management

Leukemia & lymphoma, 2023-12, Vol.64 (12), p.1905-1913

2023

Link zum Volltext

Verfügbarkeit prüfen

Nuts and bolts of COVID-19 associated coagulopathy: the essentials for management and treatment

Postgraduate medicine, 2021-11, Vol.133 (8), p.899-911

2021

Link zum Volltext

Verfügbarkeit prüfen

Thromboembolism following cesarean section: a retrospective study

Hematology (Luxembourg), 2018-07, Vol.23 (6), p.351-356

2018

Link zum Volltext

Verfügbarkeit prüfen

Incidence of unprovoked venous thromboembolic events in patients with chronic lymphocytic leukemia

Leukemia & lymphoma, 2018-02, Vol.59 (2), p.509-511

2018

Link zum Volltext

Verfügbarkeit prüfen

Venous access catheter-related thrombosis in patients with cancer

Leukemia & lymphoma, 2014-03, Vol.55 (3), p.501-508

2014

Link zum Volltext

Verfügbarkeit prüfen

Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation

Amyloid, 2021-01, Vol.28 (1), p.12-18

2021

Link zum Volltext

Verfügbarkeit prüfen

Management of venous thromboembolism in patients with acute leukemia at high bleeding risk: a multi-center study

Leukemia & lymphoma, 2016-01, Vol.57 (1), p.116-119

2016

Link zum Volltext

Verfügbarkeit prüfen

Predictors of Interventional Treatment Use for Venous Thromboembolism in Cancer Patients

Cancer investigation, 2016-09, Vol.34 (8), p.408-414

2016

Link zum Volltext

Verfügbarkeit prüfen

Diagnosis, Treatment, and Prevention of Venous Thromboembolism in Pregnancy

Postgraduate medicine, 2014-11, Vol.126 (7), p.25-34

Marshall, Ariela L.

2014

Link zum Volltext

Verfügbarkeit prüfen

A consensus viewpoint on the role of direct factor Xa inhibitors in the management of cancer-associated venous thromboembolism in the UK

Current medical research and opinion, 2023-03, Vol.39 (3), p.483-495

2023

Link zum Volltext

Verfügbarkeit prüfen

Recent developments and persisting challenges in the prevention and treatment of venous thromboembolism in patients with hematological malignancies

Leukemia & lymphoma, 2020-05, Vol.61 (6), p.1277-1291

2020

Link zum Volltext

Verfügbarkeit prüfen

Thromboembolism and in vitro fertilization – a systematic review

Acta obstetricia et gynecologica Scandinavica, 2017-09, Vol.96 (9), p.1045-1052

2017

Link zum Volltext

Verfügbarkeit prüfen

Clinical burden of venous thromboembolism

Current medical research and opinion, 2010-10, Vol.26 (10), p.2465-2473

2010

Link zum Volltext

Verfügbarkeit prüfen

An update on the efficacy and safety of novel anticoagulants for cancer associated thrombosis

Expert opinion on pharmacotherapy, 2021-03, Vol.22 (5), p.583-594

Cosmi, Benilde

2021

Link zum Volltext

Verfügbarkeit prüfen

Thrombosis and anticoagulation: clinical issues of special importance to hematologists who practice in Asia

Hematology, 2022-12, Vol.2022 (1), p.474

2022

Link zum Volltext

Verfügbarkeit prüfen

The 5 most frequently asked questions about factor Xa inhibitors

Hematology, 2022-12, Vol.2022 (1), p.515

2022

Link zum Volltext

Verfügbarkeit prüfen

Mitigating the risk of venous thromboembolism in patients with multiple myeloma receiving immunomodulatory-based therapy

Hematology, 2022-12, Vol.2022 (1), p.363

2022

Link zum Volltext

Verfügbarkeit prüfen

Long-term outcome of patients with persistent vascular obstruction on computed tomography pulmonary angiography 6 months after acute pulmonary embolism

Acta radiologica (1987), 2012-09, Vol.53 (7), p.728-731

2012

Link zum Volltext

Verfügbarkeit prüfen

Clinical and demographic factors contributing to asparaginase-associated toxicities in children with acute lymphoblastic leukemia

Leukemia & lymphoma, 2022-10, Vol.63 (12), p.2948-2954

2022

Link zum Volltext

Verfügbarkeit prüfen

Venous thromboembolism following pegaspargase in adults receiving antithrombin supplementation

Leukemia & lymphoma, 2020-07, Vol.61 (9), p.2200-2207

2020

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness and safety of anticoagulants among patients with venous thromboembolism and active cancer who also had prior bleed or prior renal disease

Current medical research and opinion, 2024-03, Vol.40 (3), p.545-553

2024

Link zum Volltext

Verfügbarkeit prüfen

The impact of advanced age on anticoagulant therapy for acute venous thromboembolism

Expert opinion on drug metabolism & toxicology, 2022-01, Vol.18 (1), p.27-37

2022

Link zum Volltext

Verfügbarkeit prüfen

The efficacy of low-dose warfarin initiation (3 mg versus 5 mg) in newly diagnosed venous thromboembolism patients among a population with a high prevalence of warfarin-sensitive haplotype of the VKORC1 gene: a randomized controlled trial

Hematology (Luxembourg), 2022-12, Vol.27 (1), p.95-104

2022

Link zum Volltext

Verfügbarkeit prüfen

Antithrombotic therapy for venous thromboembolism in patients with cancer: expert guidance

Expert opinion on pharmacotherapy, 2018-07, Vol.19 (11), p.1177-1185

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 425

Suche als RSS-Feed

Aktive Filter

KollektionTaylor & Francis:Master (3349 titles)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(417)
Mit Volltextzugriff
(224)

Publikationsform

Artikel
(424)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(399)
Science & Technology
(351)
Life Sciences & Biomedicine
(350)
Female
(181)
Anticoagulants - Therapeutic Use
(140)
Venous Thromboembolism
(115)
Male
(103)
Pharmacology & Pharmacy
(93)
Middle Aged
(91)
Adult
(84)
Risk Factors
(83)
General & Internal Medicine
(81)
Thromboembolism
(81)
Medicine, General & Internal
(80)
Thromboembolism - Drug Therapy
(80)
Aged
(77)
Thromboembolism - Prevention & Control
(77)
Venous Thromboembolism - Drug Therapy
(76)
Anticoagulants - Adverse Effects
(70)
Thromboembolism - Etiology
(65)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Current issues in venous thromboembolism

Thrombosis in multiple myeloma: mechanisms, risk assessment and management

Nuts and bolts of COVID-19 associated coagulopathy: the essentials for management and treatment

Thromboembolism following cesarean section: a retrospective study

Incidence of unprovoked venous thromboembolic events in patients with chronic lymphocytic leukemia

Venous access catheter-related thrombosis in patients with cancer

Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation

Management of venous thromboembolism in patients with acute leukemia at high bleeding risk: a multi-center study

Predictors of Interventional Treatment Use for Venous Thromboembolism in Cancer Patients

Diagnosis, Treatment, and Prevention of Venous Thromboembolism in Pregnancy

A consensus viewpoint on the role of direct factor Xa inhibitors in the management of cancer-associated venous thromboembolism in the UK

Recent developments and persisting challenges in the prevention and treatment of venous thromboembolism in patients with hematological malignancies

Thromboembolism and in vitro fertilization – a systematic review

Clinical burden of venous thromboembolism

An update on the efficacy and safety of novel anticoagulants for cancer associated thrombosis

Thrombosis and anticoagulation: clinical issues of special importance to hematologists who practice in Asia

The 5 most frequently asked questions about factor Xa inhibitors

Mitigating the risk of venous thromboembolism in patients with multiple myeloma receiving immunomodulatory-based therapy

Long-term outcome of patients with persistent vascular obstruction on computed tomography pulmonary angiography 6 months after acute pulmonary embolism

Clinical and demographic factors contributing to asparaginase-associated toxicities in children with acute lymphoblastic leukemia

Venous thromboembolism following pegaspargase in adults receiving antithrombin supplementation

Effectiveness and safety of anticoagulants among patients with venous thromboembolism and active cancer who also had prior bleed or prior renal disease

The impact of advanced age on anticoagulant therapy for acute venous thromboembolism

The efficacy of low-dose warfarin initiation (3 mg versus 5 mg) in newly diagnosed venous thromboembolism patients among a population with a high prevalence of warfarin-sensitive haplotype of the VKORC1 gene: a randomized controlled trial

Antithrombotic therapy for venous thromboembolism in patients with cancer: expert guidance

Aktive Filter

Suchergebnisse filtern